{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:02:17Z","timestamp":1780434137111,"version":"3.54.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011893","name":"PAHO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/jac\/dky414","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T20:14:09Z","timestamp":1539807249000},"page":"373-379","source":"Crossref","is-referenced-by-count":33,"title":["Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for<i>Mycobacterium tuberculosis<\/i>in the Latin American region"],"prefix":"10.1093","volume":"74","author":[{"given":"Beatriz","family":"Lopez","sequence":"first","affiliation":[{"name":"Instituto Nacional de Enfermedades Infecciosas, ANLIS \u201cDr. Carlos G Malbr\u00e1n\u201d, Departamento de Bacteriolog\u00eda, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela","family":"Siqueira de Oliveira","sequence":"additional","affiliation":[{"name":"N\u00facleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M W","family":"Pinhata","sequence":"additional","affiliation":[{"name":"N\u00facleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Chimara","sequence":"additional","affiliation":[{"name":"N\u00facleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Pacheco Ascencio","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Salud, Laboratorio de Referencia Nacional de Micobacterias, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zully M","family":"Puy\u00e9n Guerra","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Salud, Laboratorio de Referencia Nacional de Micobacterias, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Wainmayer","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Enfermedades Infecciosas ANLIS \u201cDr. Carlos G Malbr\u00e1n\u201d, Servicio de Micobacterias, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas CONICET, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Simboli","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Enfermedades Infecciosas ANLIS \u201cDr. Carlos G Malbr\u00e1n\u201d, Servicio de Micobacterias, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas CONICET, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirtha","family":"Del Granado","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Palomino","sequence":"additional","affiliation":[{"name":"Ghent University, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Ritacco","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Enfermedades Infecciosas ANLIS \u201cDr. Carlos G Malbr\u00e1n\u201d, Servicio de Micobacterias, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas CONICET, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandi","family":"Martin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 catholique de Louvain, Institute of Experimental and Clinical Research, Laboratory of Medical Microbiology, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"key\n\t\t\t\t2019012509004822800_dky414-B1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B3","year":"2012"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B4","author":"EMA."},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B5","year":"2015"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/340265","article-title":"Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium","volume":"34","author":"Till","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B7","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.46.10.3288-3291.2002","article-title":"Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection","volume":"46","author":"Yanagihara","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fort\u00fan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculosis drugs","volume":"47","author":"Alcal\u00e1","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B10","year":"2015"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B11","author":"WHO.","year":"2008","journal-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.00142914","article-title":"A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment","volume":"45","author":"Somoskovi","year":"2015","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B13","volume-title":"The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance","author":"WHO.","year":"2013"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/AAC.01113-06","article-title":"First linezolid-resistant clinical isolates of Mycobacterium tuberculosis","volume":"51","author":"Richter","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/dkl477","article-title":"Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Martin","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B16","author":"WHO"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B18","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/jac\/dkv117","article-title":"Bedaquiline susceptibility testing of Mycobacterium tuberculosis in an automated liquid culture system","volume":"70","author":"Torrea","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B19","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1128\/AAC.00614-15","article-title":"Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST","volume":"59","author":"Keller","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B20","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JCM.01123-16","article-title":"A multilaboratory, multicountry study to determine bedaquiline MIC quality control ranges for phenotypic drug susceptibility testing","volume":"54","author":"Kaniga","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12275-017-6630-1","article-title":"Bedaquiline susceptibility test for totally drug-resistant Mycobacterium tuberculosis","volume":"55","author":"Jang","year":"2017","journal-title":"J Microbiol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.medmal.2016.04.007","article-title":"In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis","volume":"46","author":"Lounis","year":"2016","journal-title":"Med Mal Infect"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ebiom.2018.01.005","article-title":"Defining bedaquiline susceptibility, resistance, cross-resistance and associated genetic determinants: a retrospective cohort study","volume":"28","author":"Ismail","year":"2018","journal-title":"EBioMedicine"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3343\/alm.2018.38.6.563","article-title":"Delamanid, bedaquiline, and linezolid minimum inhibitory concentration distributions and resistance-related gene mutations in multidrug-resistant and extensively drug-resistant tuberculosis in Korea","volume":"38","author":"Yang","year":"2018","journal-title":"Ann Lab Med"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B25","doi-asserted-by":"crossref","first-page":"384e5","DOI":"10.7883\/yoken.JJID.2009.384","article-title":"In vitro activity of linezolid against Mycobacterium tuberculosis strains isolate from Western Turkey","volume":"62","author":"Ermertcan","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5588\/ijtld.10.0238","article-title":"Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis","volume":"15","author":"Sch\u00f6n","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7883\/yoken.65.240","article-title":"In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China","volume":"65","author":"Yang","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B28","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.02020-12","article-title":"Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate","volume":"57","author":"Ahmed","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0255-0857.150967","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China","volume":"33","author":"Liu","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B30","first-page":"404","article-title":"Evaluation of drug susceptibility to rifampicin, INH and linezolid using resazurine microtitre assay","volume":"4","author":"Patidar","year":"2015","journal-title":"Int J Curr Microbiol App Sci"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1099\/jmm.0.000537","article-title":"In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria","volume":"66","author":"Aguilar-Ayala","year":"2017","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tube.2017.02.004","article-title":"Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis","volume":"104","author":"Maltempe","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B33","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","article-title":"Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance","volume":"56","author":"Diacon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B34","author":"WHO","year":"2018"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B35","author":"EUCAST."},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B36","first-page":"337","article-title":"Effectiveness and safety of imipenem\/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil","volume":"22","author":"Arbex","year":"2016","journal-title":"Rev Port Pneumol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkr500","article-title":"Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine","volume":"67","author":"Abbate","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B38","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.arbres.2015.03.012","article-title":"First series of patients with XDR and pre-XDR TB treated with regimens that included meropenem-clavulanate in Argentina","volume":"51","author":"Palmero","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B39","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.06227-11","article-title":"rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains","volume":"56","author":"Beckert","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B40","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/jac\/dkx094","article-title":"Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region","volume":"72","author":"Zimenkov","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012509004822800_dky414-B41","author":"WHO."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/2\/373\/27524617\/dky414.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T03:18:15Z","timestamp":1693970295000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/2\/373\/5144701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,25]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky414","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,25]]}}}